These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 17049061)
1. Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry. Caillard S; Lelong C; Pessione F; Moulin B; Am J Transplant; 2006 Nov; 6(11):2735-42. PubMed ID: 17049061 [TBL] [Abstract][Full Text] [Related]
2. Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score. Caillard S; Porcher R; Provot F; Dantal J; Choquet S; Durrbach A; Morelon E; Moal V; Janbon B; Alamartine E; Pouteil Noble C; Morel D; Kamar N; Buchler M; Mamzer MF; Peraldi MN; Hiesse C; Renoult E; Toupance O; Rerolle JP; Delmas S; Lang P; Lebranchu Y; Heng AE; Rebibou JM; Mousson C; Glotz D; Rivalan J; Thierry A; Etienne I; Moal MC; Albano L; Subra JF; Ouali N; Westeel PF; Delahousse M; Genin R; Hurault de Ligny B; Moulin B J Clin Oncol; 2013 Apr; 31(10):1302-9. PubMed ID: 23423742 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas. Caillard S; Lamy FX; Quelen C; Dantal J; Lebranchu Y; Lang P; Velten M; Moulin B; Am J Transplant; 2012 Mar; 12(3):682-93. PubMed ID: 22226336 [TBL] [Abstract][Full Text] [Related]
4. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses. Kasiske BL; Kukla A; Thomas D; Wood Ives J; Snyder JJ; Qiu Y; Peng Y; Dharnidharka VR; Israni AK Am J Kidney Dis; 2011 Dec; 58(6):971-80. PubMed ID: 21930332 [TBL] [Abstract][Full Text] [Related]
5. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study. OʼRegan JA; Prendeville S; McCaughan JA; Traynor C; OʼBrien FJ; Ward FL; OʼDonovan D; Kennedy C; Berzan E; Kinsella S; Williams Y; OʼKelly P; Deady S; Comber H; Leader M; Conlon PJ Transplantation; 2017 Mar; 101(3):657-663. PubMed ID: 27214265 [TBL] [Abstract][Full Text] [Related]
6. Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study. Francis A; Johnson DW; Teixeira-Pinto A; Craig JC; Wong G Nephrol Dial Transplant; 2018 May; 33(5):881-889. PubMed ID: 29342279 [TBL] [Abstract][Full Text] [Related]
7. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience. Wasson S; Zafar MN; Best J; Reddy HK J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222 [TBL] [Abstract][Full Text] [Related]
8. Incidence and outcome of post-transplant lymphoproliferative disorders in lung transplant patients: Analysis of ISHLT Registry. Zaffiri L; Long A; Neely ML; Cherikh WS; Chambers DC; Snyder LD J Heart Lung Transplant; 2020 Oct; 39(10):1089-1099. PubMed ID: 32654913 [TBL] [Abstract][Full Text] [Related]
9. Incidence of post-transplantation lymphoproliferative disease in Andalusia (1990-2009). Govantes MA; Esteve AF; Ramos MT; Gracia De Guindo MC; Sánchez LF; Blanca MA; Rodríguez-Benot A; Blandino MV; De la Nuez PC; Rodríguez DB Transplant Proc; 2013; 45(10):3592-4. PubMed ID: 24314968 [TBL] [Abstract][Full Text] [Related]
10. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients. Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV Nephrol Dial Transplant; 2012 Jul; 27(7):2971-9. PubMed ID: 22273720 [TBL] [Abstract][Full Text] [Related]
11. Incidence, Risk Factors, Clinical Management, and Outcomes of Posttransplant Lymphoproliferative Disorder in Kidney Transplant Recipients. Liu M; Husain S; Famure O; Li Y; Kim SJ Prog Transplant; 2019 Jun; 29(2):185-193. PubMed ID: 30845885 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients. Morton M; Coupes B; Roberts SA; Klapper PE; Byers RJ; Vallely PJ; Ryan K; Picton ML Transplantation; 2013 Feb; 95(3):470-8. PubMed ID: 23222821 [TBL] [Abstract][Full Text] [Related]
14. [Lymphoproliferative disorders in kidney transplant recipients: incidence, clinical characteristics and outcome]. Abderrahim E; Harzallah A; Barbouch S; Turki S; Helal I; Ben Abdallah T; Hedri H; Ben Moussa F; Bardi R; Ayed K; Ben Maïz H; Kheder A Rev Med Interne; 2008 Jul; 29(7):535-40. PubMed ID: 18262684 [TBL] [Abstract][Full Text] [Related]
15. Risk factors and clinical outcomes of pediatric liver transplant recipients with post-transplant lymphoproliferative disease in a multi-ethnic Asian cohort. Huang JG; Tan MYQ; Quak SH; Aw MM Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29071779 [TBL] [Abstract][Full Text] [Related]
17. Early onset post-transplant lymphoproliferative disease is associated with allograft localization. Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Quinlan SC; Pfeiffer RM; Morton LM; Engels EA Am J Hematol; 2011 Feb; 86(2):206-9. PubMed ID: 21264909 [TBL] [Abstract][Full Text] [Related]